BRIEF published on 11/07/2024 at 09:04, 14 days 1 hour ago RHÖN-KLINIKUM AG Shows Steady Progress in Q3 2024 Revenue Growth Healthcare Sector Financial Outlook RHÖN-KLINIKUM AG Q3 2024 Results
PRESS RELEASE published on 11/07/2024 at 08:59, 14 days 1 hour ago RHÖN-KLINIKUM AG continues solid performance in the first nine months – outlook confirmed RHÖN-KLINIKUM AG reports increased revenues and profit in the first nine months of 2024. EBITDA up by 2.3%. Outlook for 2024 confirmed amidst global uncertainties Revenues EBITDA Outlook Profit RHÖN-KLINIKUM AG
BRIEF published on 08/08/2024 at 09:05, 3 months 13 days ago First Half of 2024: RHÖN-KLINIKUM AG Continues Good Business Performance – Outlook Confirmed Revenue Growth Healthcare Sector Profit Increase RHÖN-KLINIKUM AG 2024 Financial Results
PRESS RELEASE published on 08/08/2024 at 09:00, 3 months 13 days ago First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed RHÖN-KLINIKUM AG reports 6.5% revenue increase and 68.9% profit growth in first half of 2024. Outlook for 2024 remains positive amid global uncertainties Revenue Increase Healthcare Sector Outlook 2024 Profit Growth RHÖN-KLINIKUM AG
BRIEF published on 05/08/2024 at 09:04, 6 months 13 days ago RHÖN-KLINIKUM AG Reports Strong Start to 2024 with Positive First Quarter Results 2024 Outlook Healthcare Industry Economic Impact RHÖN-KLINIKUM AG Q1 Financial Results
PRESS RELEASE published on 05/08/2024 at 08:59, 6 months 13 days ago RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter RHÖN-KLINIKUM AG reports a strong start to financial year 2024 with increased revenues and profits in Q1. The outlook for 2024 confirms positive expectations despite regulatory challenges Revenues Financial Year 2024 Outlook RHÖN-KLINIKUM AG Profits
BRIEF published on 03/28/2024 at 09:05, 7 months 24 days ago RHÖN-KLINIKUM AG Announces Positive Financial Results for 2023 Financial Results 2023 Performance Sustainability Healthcare RHÖN-KLINIKUM AG
PRESS RELEASE published on 03/28/2024 at 09:00, 7 months 24 days ago RHÖN-KLINIKUM AG looks back on successful financial year 2023 RHÖN-KLINIKUM AG reports successful financial year 2023 with increased revenues and profits. Strategic focus on core activities, outpatient care, and sustainability. Outlook for 2024 outlined Revenues Sustainability Financial Year 2023 RHÖN-KLINIKUM AG Profits
PRESS RELEASE published on 11/09/2023 at 09:00, 1 year ago RHÖN-KLINIKUM AG increases consolidated profit and revenues
PRESS RELEASE published on 08/10/2023 at 09:03, 1 year 3 months ago RHÖN-KLINIKUM Aktiengesellschaft: RHÖN-KLINIKUM AG publishes result for first half of 2023 – outlook confirmed
Published on 11/21/2024 at 10:03, 44 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 47 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 47 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 12 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 22 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 17 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 42 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 44 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 47 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 47 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 49 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 27 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 2 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 2 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
